Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report
Saved in:
| Main Authors: | Mario Valenti, Luigi Gargiulo, Luciano Ibba, Alexia Bertuzzi, Sofia Manara, Francesco Toso, Antonio Costanzo, Alessandra Narcisi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Dermatological Treatment |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2319303 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma
by: Mehmet Akce, et al.
Published: (2016-01-01) -
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience
by: Gioele Ghezzi, et al.
Published: (2024-11-01) -
Characteristics of Patients with Generalized Pustular Psoriasis: A Report of the Polish Generalized Pustular Psoriasis Group
by: Marta Kołt-Kamińska, et al.
Published: (2024-11-01) -
Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study
by: Luciano Ibba, et al.
Published: (2024-12-01) -
Successful treatment of generalized pustular psoriasis with guselkumab
by: Martina Part
Published: (2024-12-01)